| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,136 |
4,776 |
$154K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,021 |
4,116 |
$86K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,475 |
821 |
$15K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
880 |
713 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,050 |
1,794 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
2,526 |
2,121 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
952 |
901 |
$7K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
245 |
213 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,119 |
960 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
106 |
81 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
96 |
77 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,215 |
826 |
$999.92 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,688 |
1,422 |
$940.69 |
| 99215 |
Prolong outpt/office vis |
32 |
28 |
$846.89 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,154 |
980 |
$794.95 |
| 87807 |
|
155 |
148 |
$771.56 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,188 |
988 |
$735.60 |
| 80061 |
Lipid panel |
509 |
449 |
$672.72 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
725 |
513 |
$605.54 |
| 80076 |
|
1,100 |
920 |
$587.24 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
216 |
172 |
$514.44 |
| 84439 |
|
774 |
675 |
$432.72 |
| 80305 |
|
258 |
212 |
$405.21 |
| 80053 |
Comprehensive metabolic panel |
32 |
32 |
$401.43 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,699 |
1,156 |
$389.25 |
| 99490 |
Ccm add 20min |
25 |
16 |
$164.63 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
31 |
26 |
$86.40 |
| 81003 |
|
72 |
49 |
$74.00 |
| 81002 |
|
48 |
39 |
$52.29 |
| 83721 |
|
49 |
40 |
$8.91 |
| 3079F |
|
253 |
196 |
$0.00 |
| 99000 |
|
439 |
330 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
81 |
68 |
$0.00 |
| 3075F |
|
62 |
55 |
$0.00 |
| 1036F |
|
139 |
112 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
15 |
13 |
$0.00 |
| 3008F |
|
308 |
247 |
$0.00 |
| 1125F |
|
38 |
28 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
98 |
87 |
$0.00 |
| 3074F |
|
15 |
12 |
$0.00 |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
18 |
13 |
$0.00 |
| 1126F |
|
14 |
12 |
$0.00 |
| 90674 |
|
15 |
13 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
321 |
252 |
$0.00 |
| 3077F |
|
159 |
121 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
12 |
12 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
102 |
85 |
$0.00 |
| 99307 |
|
13 |
12 |
$0.00 |
| 3078F |
|
171 |
136 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
106 |
91 |
$0.00 |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
13 |
12 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
33 |
27 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
58 |
49 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
32 |
29 |
$0.00 |
| 4040F |
|
54 |
48 |
$0.00 |
| 1124F |
|
89 |
81 |
$0.00 |